fluoxetine has been researched along with As If Personality in 37 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study is to identify associations between regional serotonin transporter (5-HTT) availability and trait and state aggression, as well as response to the anti-aggressive effects of fluoxetine." | 8.31 | Serotonin transporter availability in physically aggressive personality disordered patients: associations with trait and state aggression, and response to fluoxetine. ( Abi-Dargham, A; Carson, RE; Hazlett, EA; Huang, Y; Koenigsberg, HW; McClure, MM; Nabulsi, N; New, AS; Perez-Rodriguez, MM; Rosell, DR; Siever, LS; Slifstein, M; Thompson, J; Xu, X, 2023) |
| "Combined therapy with adapted IPT was superior to fluoxetine alone in BPD patients, concerning a few core symptoms of the disorder, anxiety, and quality of life." | 5.14 | Adaptation of interpersonal psychotherapy to borderline personality disorder: a comparison of combined therapy and single pharmacotherapy. ( Bellino, S; Bogetto, F; Rinaldi, C, 2010) |
| "Fluoxetine, but not placebo, treatment resulted in a sustained reduction in scores on the Irritability and Aggression subscales of the Overt Aggression Scale-Modified for Outpatients that was first apparent during months 2 and 3 of treatment, respectively." | 5.08 | Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. ( Coccaro, EF; Kavoussi, RJ, 1997) |
| "The aim of this study is to identify associations between regional serotonin transporter (5-HTT) availability and trait and state aggression, as well as response to the anti-aggressive effects of fluoxetine." | 4.31 | Serotonin transporter availability in physically aggressive personality disordered patients: associations with trait and state aggression, and response to fluoxetine. ( Abi-Dargham, A; Carson, RE; Hazlett, EA; Huang, Y; Koenigsberg, HW; McClure, MM; Nabulsi, N; New, AS; Perez-Rodriguez, MM; Rosell, DR; Siever, LS; Slifstein, M; Thompson, J; Xu, X, 2023) |
| "Two hundred and fifteen outpatients with major depressive disorder as assessed with the Structured Clinical Interview for DSM-III-R (SCID-P) were treated openly with fluoxetine 20 mg/day for 8 weeks." | 3.70 | Residual symptoms in depressed patients who respond acutely to fluoxetine. ( Alpert, JE; Fava, M; Keefe, BR; Leslie, VC; Nierenberg, AA; Pava, JA; Rosenbaum, JF; Worthington, JJ, 1999) |
| "Although selective serotonin reuptake inhibitors (SSRI) are generally effective in reducing impulsive aggression in individuals with intermittent explosive disorder, a large proportion of intermittent explosive disorder patients fail to achieve full remission despite adequate dosage and duration of treatment." | 2.76 | Personality predictors of antiaggressive response to fluoxetine: inverse association with neuroticism and harm avoidance. ( Coccaro, EF; Lee, R; Phan, KL, 2011) |
| "Personality disorders are neither particularly stable nor treatment resistant." | 2.75 | Personality disorders improve in patients treated for major depression. ( Frampton, CM; Joyce, PR; Mulder, RT, 2010) |
| "Treatment with fluoxetine is less likely to lead to remission of MDD in patients with stable PDs." | 2.72 | Problem-solving ability and comorbid personality disorders in depressed outpatients. ( Farabaugh, A; Fava, M; Harley, R; Papakostas, GI; Petersen, T; Scalia, M, 2006) |
| " Divalproex sodium was increased as tolerated using a flexible dosing schedule." | 2.69 | Divalproex sodium for impulsive aggressive behavior in patients with personality disorder. ( Coccaro, EF; Kavoussi, RJ, 1998) |
| "Patients with unipolar depression and anger attacks frequently experience significant anxiety and somatic symptoms, and are relatively more likely to meet criteria for avoidant, dependent, borderline, narcissistic, and antisocial personality disorders than depressed patients without these attacks." | 2.40 | Depression with anger attacks. ( Fava, M, 1998) |
| "Persistence of hypochondriasis was individually predicted by longer duration of prior hypochondriasis (P = 0." | 1.37 | Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment. ( Fallon, BA; Pavlicova, M; Schweitzer, PJ; Zafar, U, 2011) |
| "Patients meeting DSM-IV criteria for major depressive disorder (MDD) entered randomized, controlled medication trials." | 1.30 | Defense mechanisms and personality in depression. ( Blanco, C; Mullen, LS; Roose, SP; Vaughan, R; Vaughan, SC, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (43.24) | 18.2507 |
| 2000's | 14 (37.84) | 29.6817 |
| 2010's | 6 (16.22) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Rosell, DR | 1 |
| Slifstein, M | 1 |
| Thompson, J | 1 |
| Xu, X | 1 |
| Perez-Rodriguez, MM | 1 |
| McClure, MM | 1 |
| Hazlett, EA | 1 |
| New, AS | 1 |
| Nabulsi, N | 1 |
| Huang, Y | 1 |
| Carson, RE | 1 |
| Siever, LS | 1 |
| Abi-Dargham, A | 1 |
| Koenigsberg, HW | 1 |
| Candrian, M | 2 |
| Schwartz, F | 2 |
| Farabaugh, A | 4 |
| Perlis, RH | 1 |
| Ehlert, U | 1 |
| Fava, M | 11 |
| Mulder, RT | 6 |
| Frampton, CM | 2 |
| Luty, SE | 5 |
| Joyce, PR | 6 |
| Dording, CM | 1 |
| Sinicropi-Yao, L | 1 |
| Papakostas, G | 1 |
| Matthews, JD | 1 |
| Nierenberg, AA | 4 |
| Mischoulon, D | 2 |
| Silva, H | 1 |
| Iturra, P | 1 |
| Solari, A | 1 |
| Villarroel, J | 1 |
| Jerez, S | 1 |
| Jiménez, M | 1 |
| Galleguillos, F | 1 |
| Bustamante, ML | 1 |
| Bellino, S | 2 |
| Rinaldi, C | 1 |
| Bogetto, F | 2 |
| Ginsburg, GS | 1 |
| Silva, SG | 1 |
| Jacobs, RH | 1 |
| Tonev, S | 1 |
| Hoyle, RH | 1 |
| Kingery, JN | 1 |
| Reinecke, MA | 1 |
| Curry, JF | 1 |
| March, JS | 1 |
| De Bolle, M | 1 |
| De Fruyt, F | 1 |
| Quilty, LC | 1 |
| Rolland, JP | 1 |
| Decuyper, M | 1 |
| Bagby, RM | 1 |
| Schweitzer, PJ | 1 |
| Zafar, U | 1 |
| Pavlicova, M | 1 |
| Fallon, BA | 1 |
| Phan, KL | 1 |
| Lee, R | 1 |
| Coccaro, EF | 5 |
| Agosti, V | 1 |
| McGrath, PJ | 1 |
| Farabaugh, AH | 1 |
| Sickinger, AH | 1 |
| Wright, E | 1 |
| Alpert, JE | 3 |
| Sonawalla, S | 1 |
| Worthington, JJ | 2 |
| Rogers, GR | 1 |
| Miller, AL | 1 |
| Kennedy, MA | 1 |
| McKenzie, JM | 2 |
| Carter, JD | 1 |
| Sullivan, PF | 2 |
| Cloninger, CR | 1 |
| McIntosh, VV | 1 |
| Carter, FA | 1 |
| Bulik, CM | 1 |
| Harley, R | 1 |
| Petersen, T | 1 |
| Scalia, M | 1 |
| Papakostas, GI | 1 |
| Pender, M | 1 |
| Alpert, J | 1 |
| Huppert, JD | 1 |
| Strunk, DR | 1 |
| Ledley, DR | 1 |
| Davidson, JR | 1 |
| Foa, EB | 1 |
| Pizzagalli, DA | 1 |
| Baer, L | 1 |
| Tuinier, S | 1 |
| Verhoeven, WM | 1 |
| Barzega, G | 1 |
| Maina, G | 1 |
| Ravizza, L | 1 |
| Bouffides, E | 2 |
| Pava, JA | 3 |
| McCarthy, MK | 2 |
| Steingard, RJ | 2 |
| Rosenbaum, JF | 4 |
| Shea, MT | 1 |
| Akiskal, H | 1 |
| Tedlow, JR | 1 |
| Uebelacker, LA | 1 |
| Black, KJ | 1 |
| Sheline, YI | 1 |
| Kavoussi, RJ | 3 |
| Hauger, RL | 1 |
| Benjamin, LS | 1 |
| Keefe, BR | 1 |
| Leslie, VC | 1 |
| Mullen, LS | 1 |
| Blanco, C | 1 |
| Vaughan, SC | 1 |
| Vaughan, R | 1 |
| Roose, SP | 1 |
| Astill, JL | 1 |
| Herbert, JL | 1 |
| Schut, AG | 1 |
4 reviews available for fluoxetine and As If Personality
| Article | Year |
|---|---|
Dimensional classification and behavioral pharmacology of personality disorders; a review and hypothesis.
Topics: Adaptation, Psychological; Antipsychotic Agents; Borderline Personality Disorder; Clinical Trials as | 1995 |
Personality disorders and depression: an overview of issues and findings.
Topics: Comorbidity; Depressive Disorder; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Pe | 1993 |
Special feature: personality disorders: models for treatment and strategies for treatment development.
Topics: Adult; Behavior Therapy; Clinical Protocols; Clinical Trials as Topic; Cognitive Behavioral Therapy; | 1997 |
Depression with anger attacks.
Topics: Aggression; Ambulatory Care; Anger; Antidepressive Agents; Arousal; Comorbidity; Depressive Disorder | 1998 |
21 trials available for fluoxetine and As If Personality
| Article | Year |
|---|---|
Personality disorders and perceived stress in major depressive disorder.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Comorbidity; Depressive Disorder, Major; Diagnostic and St | 2008 |
Eighteen months of drug treatment for depression: predicting relapse and recovery.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Dose-Response R | 2009 |
The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorder.
Topics: Adolescent; Adult; Aged; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Dis | 2009 |
Personality disorders improve in patients treated for major depression.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Comorbidity; Depressive Disorder, Major; Dose-Respon | 2010 |
Adaptation of interpersonal psychotherapy to borderline personality disorder: a comparison of combined therapy and single pharmacotherapy.
Topics: Adolescent; Adult; Affective Symptoms; Antidepressive Agents, Second-Generation; Anxiety; Combined M | 2010 |
Cognitive measures of adolescent depression: unique or unitary constructs?
Topics: Adolescent; Child; Cognition Disorders; Cognitive Behavioral Therapy; Culture; Depressive Disorder, | 2009 |
Does personality disorder co-morbidity impact treatment outcome for patients with major depression? A multi-level analysis.
Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Depressive Disorder, Major; Female; Fluoxetine; | 2011 |
Personality predictors of antiaggressive response to fluoxetine: inverse association with neuroticism and harm avoidance.
Topics: Adult; Aggression; Avoidance Learning; Fluoxetine; Harm Reduction; Humans; Male; Middle Aged; Neurot | 2011 |
Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Child | 2002 |
The relationship of personality disorders to treatment outcome in depressed outpatients.
Topics: Adult; Age Factors; Ambulatory Care; Antidepressive Agents; Chronic Disease; Comorbidity; Depressive | 2003 |
Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders.
Topics: Adult; Alleles; Character; Exons; Exploratory Behavior; Female; Fluoxetine; Genotype; Humans; Male; | 2003 |
Bipolar II disorder: personality and outcome in two clinical samples.
Topics: Adrenergic Uptake Inhibitors; Adult; Bipolar Disorder; Bulimia; Cognitive Behavioral Therapy; Depres | 2004 |
Problem-solving ability and comorbid personality disorders in depressed outpatients.
Topics: Adult; Antidepressive Agents, Second-Generation; Aptitude; Comorbidity; Depressive Disorder, Major; | 2006 |
Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD.
Topics: Adult; Antidepressive Agents, Second-Generation; Attitude; Cognition Disorders; Cognitive Behavioral | 2007 |
Generalized social anxiety disorder and avoidant personality disorder: structural analysis and treatment outcome.
Topics: Activities of Daily Living; Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbid | 2008 |
Perceived stress and cognitive vulnerability mediate the effects of personality disorder comorbidity on treatment outcome in major depressive disorder: a path analysis study.
Topics: Acute Disease; Adolescent; Adult; Ambulatory Care; Cognition Disorders; Comorbidity; Depressive Diso | 2007 |
Are study dropouts different from completers?
Topics: Adult; Antidepressive Agents, Second-Generation; Comorbidity; Depressive Disorder; Female; Fluoxetin | 1996 |
Personality disorder scores improve with effective pharmacotherapy of depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Ergolines; Female; Fluoxetine; | 1997 |
Serotonin function and antiaggressive response to fluoxetine: a pilot study.
Topics: Adolescent; Adolescent Behavior; Adult; Aggression; Double-Blind Method; Fenfluramine; Fluoxetine; H | 1997 |
Fluoxetine and impulsive aggressive behavior in personality-disordered subjects.
Topics: Adult; Aggression; Double-Blind Method; Fluoxetine; Humans; Impulsive Behavior; Male; Patient Dropou | 1997 |
Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.
Topics: Adult; Aggression; Anticonvulsants; Antimanic Agents; Female; Fluoxetine; Humans; Impulsive Behavior | 1998 |
12 other studies available for fluoxetine and As If Personality
| Article | Year |
|---|---|
Serotonin transporter availability in physically aggressive personality disordered patients: associations with trait and state aggression, and response to fluoxetine.
Topics: Aggression; Fluoxetine; Humans; Personality; Personality Disorders; Positron-Emission Tomography; Se | 2023 |
Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder.
Topics: Adolescent; Adult; Aged; Aggression; Alleles; Female; Fluoxetine; Genotype; Humans; Impulsive Behavi | 2010 |
Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment.
Topics: Adolescent; Adult; Aged; Child Abuse; Clinical Trials as Topic; Diagnostic and Statistical Manual of | 2011 |
Personality disorders and depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cluster Analysis; Comorbidity; Depression; Female; F | 2002 |
Temperament, childhood environment and psychopathology as risk factors for avoidant and borderline personality disorders.
Topics: Adolescent; Adult; Borderline Personality Disorder; Child; Demography; Depressive Disorder, Major; F | 2003 |
[Personality disorders and obsessive-compulsive disorder: critical analysis of the literature data and our studies].
Topics: Clomipramine; Comorbidity; Depressive Disorder; Fluoxetine; Humans; Obsessive-Compulsive Disorder; P | 1995 |
Personality disorder comorbidity with major depression and response to fluoxetine treatment.
Topics: Adolescent; Adult; Aged; Cluster Analysis; Comorbidity; Depressive Disorder; Dose-Response Relations | 1994 |
Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Anger; Comorbidity; Depressive Disorder; Diagnosis, Differ | 1993 |
[Dysthymic disorder and its treatment].
Topics: Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Fluoxetine; Humans; Personal | 1993 |
Residual symptoms in depressed patients who respond acutely to fluoxetine.
Topics: Adult; Age of Onset; Ambulatory Care; Cognitive Behavioral Therapy; Comorbidity; Depressive Disorder | 1999 |
Defense mechanisms and personality in depression.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Defense Mechanisms; Depressive Disorder, Major; Female; | 1999 |
Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients.
Topics: Adult; Aggression; Antisocial Personality Disorder; Borderline Personality Disorder; Disruptive, Imp | 1990 |